[1]蒋云霞,罗伟生.理气药治疗肝纤维化作用的研究进展[J].西部中医药,2023,36(04):133-136.[doi:10.12174/j.issn.2096-9600.2023.04.31]
 JIANG Yunxia,LUO Weisheng.Research Progress of Regulating-Qi Drugs in the Treatment of Liver Fibrosis[J].Western Journal of Traditional Chinese Medicine,2023,36(04):133-136.[doi:10.12174/j.issn.2096-9600.2023.04.31]
点击复制

理气药治疗肝纤维化作用的研究进展
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年04期
页码:
133-136
栏目:
动态·研究进展
出版日期:
2023-04-15

文章信息/Info

Title:
Research Progress of Regulating-Qi Drugs in the Treatment of Liver Fibrosis
作者:
蒋云霞, 罗伟生
广西中医药大学,广西 南宁,530000
Author(s):
JIANG Yunxia, LUO Weisheng
Guangxi University of Chinese Medicine, Nanning 530000, China
关键词:
肝纤维化理气中医中药研究进展
Keywords:
liver fibrosisregulatingtraditional Chinese medicineresearch progress
分类号:
R256.43
DOI:
10.12174/j.issn.2096-9600.2023.04.31
文献标志码:
A
摘要:
对理气类中药,如香附、荔枝核、小茴香及化瘀理气类中药,如郁金、姜黄、莪术治疗肝纤维化的作用机制及相关研究进行梳理。认为在药物的抗肝纤维化作用机制研究方面,仍缺乏完整、准确的对分子机制及其信号传导通路的研究。在之后的研究与实验过程中,应立足于中医理论与古籍论述,发展现代的药剂药理学实验与临床研究,更为深入地探讨各味中药是否具有治疗肝纤维化的作用及其相关机制,并将其合理运用到之后的中药研制与开发当中。
Abstract:
The paper reviews the mechanism and the relevant study on regulating-Qi herbs including Xiangfu (Cyperi rhizoma), Lizhihe (Litchi semen), Xiaohuixiang (Foeniculi fructus), and stagnation-resolving Qi-regulating herbs such as Yujin (Curcumae Radix), Jianghuang (Curcumae longae rhizoma), Ezhu (Curcumae rhizoma) in the treatment of liver fibrosis. The research on the mechanism of anti-liver fibrosis action of drugs lacks the complete and accurate studies on molecular mechanism and its signaling pathways. In the subsequent research and experimental process, modern pharmacological pharmacology experiments and clinical research should be developed based on the theory of traditional Chinese medicine and ancient books, in order to further discuss whether different herbs owns therapeutic effects for liver fibrosis and the relevant mechanism, and it will be rationally applied to the later development of herbs.

相似文献/References:

[1]于立友,汪龙德△,张晶,等.化纤保肝方治疗气滞血瘀型肝纤维化的临床研究*[J].西部中医药,2013,26(10):84.
 YU Liyou,WANG Longde,ZHANG Jing,et al.Clinical Study on HuaQian BaoGan Prescription in the Treatment for Hepatic Fibrosis of Qi Staganation and Blood Stasis Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(04):84.
[2]刘成,杨宗国,陆云飞,等.消黄方对大鼠胆汁淤积性肝纤维化的干预作用*[J].西部中医药,2012,25(11):14.
 LIU Cheng,YANG Zong-guo,LU Yun-fei,et al.Therapeutic Effects of XiaoHuangFang on Cholestatic Liver Fibrosis in Rats[J].Western Journal of Traditional Chinese Medicine,2012,25(04):14.
[3]郭守强.苦参碱对肝纤维化大鼠转化生长因子β1表达的影响[J].西部中医药,2014,27(06):13.
 GUO Shouqiang.The Effects of Matrine on the Expressions of TGF-β1 of the Rats with Liver Fibrosis[J].Western Journal of Traditional Chinese Medicine,2014,27(04):13.
[4]闫雪华.恩替卡韦联合复方鳖甲软肝片治疗代偿期乙肝肝硬化疗效观察[J].西部中医药,2014,27(07):84.
 YAN Xuehua.Clinical Observation on Entecavir Combined with Compound BieJia RuanGan Tablets in Treating Decompensated Liver Cirrhosis of Hepatitis B[J].Western Journal of Traditional Chinese Medicine,2014,27(04):84.
[5]陈耀章,李根旺.冬虫夏草对心肝肾的保护作用研究[J].西部中医药,2016,29(04):127.
 CHEN Yaozhang,LI Genwang.Study on the Protective Effects of DongChong XiaCao to Heart, Liver and Kidney[J].Western Journal of Traditional Chinese Medicine,2016,29(04):127.
[6]张玉玲,闫雪华△,谢青.中药联合抗病毒药物治疗HBV所致肝纤维化的研究进展[J].西部中医药,2019,32(06):149.
 ZHANG Yuling,YAN Xuehua,XIE Qing.The Progress of Herbs Joined with Antiviral Drugs in the Treatment for HBV - induced Hepatic Fibrosis[J].Western Journal of Traditional Chinese Medicine,2019,32(04):149.
[7]段桂姣,王振常,吴珊珊.柔肝化纤颗粒对肝纤维化模型大鼠肝组织超氧化物歧化酶和丙二醛的影响[J].西部中医药,2022,35(04):30.[doi:10.12174/j.issn.2096-9600.2022.04.08]
 DUAN Guijiao,WANG Zhenchang,Wu Shanshan.Effects of Rougan Huaxian Granules on SOD and MDA in Liver Tissue of Rats with Hepatic Fibrosis[J].Western Journal of Traditional Chinese Medicine,2022,35(04):30.[doi:10.12174/j.issn.2096-9600.2022.04.08]
[8]徐俊,戚璐,许杰,等.抗纤软肝颗粒对肝纤维化小鼠肠道黏膜通透性的影响[J].西部中医药,2022,35(07):27.[doi:10.12174/j.issn.2096-9600.2022.07.07]
 XU Jun,QI Lu,XU Jie,et al.Influence of Anti-fibrosis Liver-softening Granules on Intestinal Mucosal Permeability in Hepatic Fibrosis Mice[J].Western Journal of Traditional Chinese Medicine,2022,35(04):27.[doi:10.12174/j.issn.2096-9600.2022.07.07]
[9]李莎,焦战,陈青,等.瞬时弹性成像技术评价自拟中药治疗肝纤维化的临床疗效[J].西部中医药,2020,33(08):89.[doi:10.12174/j.issn.1004-6852.2020.08.23]
 LI Sha,JIAO Zhan,CHEN Qing,et al.Clinical Effects of Selfmade Herbs in Treating Liver Fibrosis Evaluated by Transient Elastography[J].Western Journal of Traditional Chinese Medicine,2020,33(04):89.[doi:10.12174/j.issn.1004-6852.2020.08.23]
[10]陈懿榕,阙任烨,刘进锴,等.柴胡皂苷d对大鼠肝星状细胞TGFβ-Smad信号通路mRNA表达的影响[J].西部中医药,2022,35(08):15.[doi:10.12174/j.issn.2096-9600.2022.08.04]
 CHEN Yirong,QUE Renye,LIU Jinkai,et al.Influence of Saikosaponins-d on the Expressions of TGFβ-Smad Signal Path mRNA in Rat Hepatic Stellate Cells[J].Western Journal of Traditional Chinese Medicine,2022,35(04):15.[doi:10.12174/j.issn.2096-9600.2022.08.04]

备注/Memo

备注/Memo:
蒋云霞(1995—),女,硕士学位,住院医师。研究方向:脾胃病及传染性疾病的中医药防治。国家自然科学基金(81660779);广西创新驱动发展专项公开择优立项项目(基金号:2017AA21041);2018年广西一流学科建设项目重点课题(2018XK035)。
更新日期/Last Update: 2023-04-15